XML 25 R3.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Net sales $ 1,888,634 $ 1,839,686 $ 1,953,313
Cost of goods sold (excluding amortization expense - See Note 15) 1,209,262 1,153,656 1,247,669
Gross profit 679,372 686,030 705,644
Selling, general and administrative expenses 502,416 484,794 483,561
Impairment charges 88,840 0 0
Restructuring and related charges, net 35,130 6,530 7,588
Operating income 52,986 194,706 214,495
Other (expense) income, net (1,909) 1,354 (10,672)
Interest expense (44,048) (41,002) (50,699)
Income before taxes and equity in net income of associated companies 7,029 155,058 153,124
Taxes on income before equity in net income of associated companies 24,607 49,300 55,585
(Loss) income before equity in net income of associated companies (17,578) 105,758 97,539
Equity in net income of associated companies 15,177 10,971 15,333
Net (loss) income (2,401) 116,729 112,872
Less: Net income attributable to noncontrolling interest 87 85 124
Net (loss) income attributable to Quaker Chemical Corporation $ (2,488) $ 116,644 $ 112,748
Per share data:      
Net (loss) income attributable to Quaker Chemical Corporation common shareholders– basic (in dollars per share) $ (0.14) $ 6.51 $ 6.27
Net (loss) income attributable to Quaker Chemical Corporation common shareholders – diluted (in dollars per share) $ (0.14) $ 6.51 $ 6.26